SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses

Dennis Christensen, Charlotta Polacek, Daniel J. Sheward, Leo Hanke, Gerald McInerney, Ben Murrell, Katrine Top Hartmann, Henrik Elvang Jensen, Julie Zimmermann, Gregers Jungersen, Kristin Engelhart Illigen, Louise Krag Isling, Carlota Fernandez-Antunez, Carlota Fernandez-Antunez, Santseharay Ramirez, Santseharay Ramirez, Jens Bukh, Jens Bukh, Gabriel Kristian Pedersen

Open source

DOI: 10.3389/fimmu.2023.941281
Published: 1
Container: Frontiers in Immunology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.941281,
  title = {SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses},
  author = {Dennis Christensen and Charlotta Polacek and Daniel J. Sheward and Leo Hanke and Gerald McInerney and Ben Murrell and Katrine Top Hartmann and Henrik Elvang Jensen and Julie Zimmermann and Gregers Jungersen and Kristin Engelhart Illigen and Louise Krag Isling and Carlota Fernandez-Antunez and Carlota Fernandez-Antunez and Santseharay Ramirez and Santseharay Ramirez and Jens Bukh and Jens Bukh and Gabriel Kristian Pedersen},
  year = {2023},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2023.941281},
  url = {https://doi.org/10.3389/fimmu.2023.941281}
}

RIS

TY  - JOUR
TI  - SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses
AU  - Dennis Christensen
AU  - Charlotta Polacek
AU  - Daniel J. Sheward
AU  - Leo Hanke
AU  - Gerald McInerney
AU  - Ben Murrell
AU  - Katrine Top Hartmann
AU  - Henrik Elvang Jensen
AU  - Julie Zimmermann
AU  - Gregers Jungersen
AU  - Kristin Engelhart Illigen
AU  - Louise Krag Isling
AU  - Carlota Fernandez-Antunez
AU  - Carlota Fernandez-Antunez
AU  - Santseharay Ramirez
AU  - Santseharay Ramirez
AU  - Jens Bukh
AU  - Jens Bukh
AU  - Gabriel Kristian Pedersen
PY  - 2023
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2023.941281
UR  - https://doi.org/10.3389/fimmu.2023.941281
ER  -

APA

Christensen, D., Polacek, C., Sheward, D. J., Hanke, L., McInerney, G., Murrell, B., Hartmann, K. T., Jensen, H. E., Zimmermann, J., Jungersen, G., Illigen, K. E., Isling, L. K., Fernandez-Antunez, C., Fernandez-Antunez, C., Ramirez, S., Ramirez, S., Bukh, J., Bukh, J., & Pedersen, G. K. (2023). SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.941281

Source records

doaj · retrieved 2026-09-26T05:21:23.168Z